Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

20 hrs ago | AmericanBankingNews.com

GlaxoSmithKline plc Receives Hold Rating from Deutsche Bank

Shares of GlaxoSmithKline plc traded down 0.04% on Friday, hitting $47.68. 2,687,318 shares of the company's stock traded hands.

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

Yesterday | ETaiwanNews.com

GlaxoSmithKline agrees to $105 million settlement

Under the settlement announced Wednesday, the London-based pharmaceutical also agreed to rules that bar it from paying doctors to promote its products; providing financial incentives that encourage salespeople to market s using results from inadequate studies or making unapproved claims that a product was "better, more effective, safer or has less ... (more)

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Sales, San Diego County, CA, Marketing

Yesterday | BioSpace

After Losing GlaxoSmithKline Deal, Pozen, Inc. Takes Another Step To No Longer Be A Drug Developer

Chapel Hill's Pozen completed a deal in which it ended a relationship with GlaxoSmithKline and took another step farther away from being a drug developer.

Comment?

Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, GlaxoSmithKline, Research Triangle Park, NC

Thu Aug 21, 2014

Seeking Alpha

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market

Theravance is probably a familiar name to many of you. The pharmaceutical company has received extensive coverage on Seeking Alpha over the years.

Comment?

Related Topix: Startups, Theravance, Copd, Medicine, Health, Biotech, GlaxoSmithKline, Healthcare Industry

HeraldSun.com

Rescue Mission's giveaway prepares kids for school

Essynce Boswell, 5, slides down an inflatable slide during the 15th annual Durham Rescue Mission back-to-school party on Thursday, August 21, 2014.

Comment?

Related Topix: Family, Kids, GlaxoSmithKline, Biotech, Medicine, Healthcare Industry, Hurricane, Weather, Hurricane Sandy, Durham, NC

JD Supra

What Can You Do When Risk Changes in a Third Party Relationship?

The GlaxoSmithKline PLC corruption matter in China continues to reverberate throughout the international business community, inside and outside China.

Comment?

Related Topix: Biotech, Privacy, US News

Seeking Alpha

Amgen Has Yet To Reach Its Potential, Despite Strong Gains

With shares of Amgen trading at near 52-week highs, investors are getting nervous about the next couple of quarters.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Johnson and Johnson, Pfizer

Business Journal

Analysts: Recent bouts of bad press could pose buying opportunity for GSK investors

It's been a bad few months for GlaxoSmithKline , the British based company with North American headquarters in Research Triangle Park.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Asthma, Health

Brand Republic

Wunderman wins global GSK pitch

GlaxoSmithKline is set to appoint Wunderman as the lead agency on its global digital advertising account after a pitch that began last year.

Comment?

Related Topix: Wunderman, Advertising, Biotech, GlaxoSmithKline, Healthcare Industry

Wed Aug 20, 2014

Sys-Con Media

North American Pharma-Biotech Sector to Wrap Up Construction on 157...

Midway through the third quarter of 2014, the Pharmaceutical-Biotech Industry is busy finishing an impressive array of capital construction projects.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, BioMed Realty Trust, Sugar Land, TX

BioSpace

Pozen, Inc. Announces U.S. Rights For TREXIMET?? Have Been Acquired By Pernix Therapeutics, Inc.

POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the acquisition of all of GlaxoSmithKline's rights to TreximetA have been acquired by Pernix Therapeutics Holdings, Inc. .

Comment?

Related Topix: Biotech, Medicine, Pozen, Healthcare Industry

Benzinga

GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma

GlaxoSmithKline plc today announced that the FDA has approved Arnuitya ElliptaA , a once-daily inhaled corticosteroid medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older.

Comment?

Related Topix: Medicine, Asthma, Health, Biotech, GlaxoSmithKline, Healthcare Industry, Fluticasone (generic), Flovent

Seeking Alpha

GlaxoSmithKline: The Bad Isn't All That Bad

But is this merely a buying opportunity for a solid company? It trades as one of the cheapest pharma companies around and offers one of the best dividend yields.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Wall Street Journal

Mylan Edges Toward Glaxo Drugs

U.S. generic drugs company Mylan Inc., private equity groups TPG Capital LLP, Advent International, KKR & Co L.P., and Warburg Pincus LLC, and some Indian drug makers have made it through to the second round of bidding for a portfolio of mature drugs being sold by GlaxoSmithKline PLC, according to people familiar with the sales process.

Comment?

Related Topix: Startups, Warburg Pincus, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

The Motley Fool

If You Want Dividend Income, Look No Further than GlaxoSmithKline plc Stock

Dividends: They're the cornerstone to any healthy, long-term-focused portfolio. But when it comes to the health care industry, securing dividend income isn't as easy as it sounds.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Food and Drug Administration

TheStreet.com

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Genetics

TheStreet.com

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

CEO John Crowley came close to permanently shelving his company's experimental Fabry disease therapy following disappointing results from a late-stage study in December 2012 and the departure of partner GlaxoSmithKline about one year later.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Genetics, Business News

Tue Aug 19, 2014

Business Journal

Sanford-Burnham Medical Research Institute gets new leader

Sanford-Burnham Medical Research Institute on Aug. 19 announced it has selected Dr. Perry Nisen as CEO at its La Jolla, Calif.-based headquarters.

Comment?

Related Topix: United Kingdom, Greater London County, England, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Seeking Alpha

GlaxoSmithKline: To Buy Or Not To Buy?

GlaxoSmithKline is a global pharmaceutical company known for producing a variety of drugs and consumer goods such as AquaFresh toothpaste, Tums gastrointestinal aid, and Amoxil antibiotic.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Amoxicillin (generic), Amoxil, Trimox, Diabetes, Health

Mon Aug 18, 2014

GuruFocus.com

Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

According to GuruFocus list of 52-week lows , these Guru stocks have reached their 52-week lows.

Comment?

Related Topix: Financial Markets, Pfizer, Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Vodafone Group, Telecom

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••